T. Jauch

Inhibition of TGF-β2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

J. Pichler, U. Bogdahn, G. Schuierer, 2007 .

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.

J. Pichler, U. Bogdahn, G. Schuierer, 2007, Oligonucleotides.

Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma

U. Bogdahn, K. Fabel, A. Brawanski, 2004, Cancer.

Salvage therapy in patients with glioblastoma

U. Bogdahn, G. Schuierer, K. Fabel, 2003, Cancer.